MyAverix Finance MyAverix Finance

HK

Guangzhou Baiyunshan Pharmaceutical Holdings Co. Ltd. (874)

Guangzhou Baiyunshan Pharmaceutical Holdings Co. Ltd. (874) is listed on HK. As of 2026-05-21, reported P/E ratio is 18.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Data as of 2026-05-21

Download on the App Store Get it on Google Play

Download free on iPhone and Android

Key metrics for 874

P/E ratio
18.00

Guangzhou Baiyunshan Pharmaceutical Holdings Co. Ltd. (874) — FAQ

What is 874's P/E ratio?

The price-to-earnings (P/E) ratio for Guangzhou Baiyunshan Pharmaceutical Holdings Co. Ltd. (874) is 18.00 (data as of 2026-05-21).

Does Guangzhou Baiyunshan Pharmaceutical Holdings Co. Ltd. pay a dividend?

Dividend yield is not available in the current snapshot for Guangzhou Baiyunshan Pharmaceutical Holdings Co. Ltd. (874). Check the MyAverix Finance app for the latest dividend data.

What exchange is 874 listed on?

874 is listed on HK.

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

← All stocks

MyAverix Finance provides company information and financial data for educational and research purposes only. We are not a broker, advisor, or investment service. Data may be delayed or incomplete. Past performance does not guarantee future results. Always do your own research before making financial decisions.

Terms of Use

App Store Google Play